For Inspection Restart, US FDA Urged To Prioritize Foreign Supply Chains, Uninspected Sites

CRN “urges FDA to pay special attention to international supply chains, ingredient identity and purity validation,” and CHPA suggests it make progress on facilities it has not previously inspected.